Drug Profile
Suriclone
Alternative Names: RP 31264Latest Information Update: 23 May 1995
Price :
$50
*
At a glance
- Originator Aventis
- Class Anxiolytics; Inorganic sulfur compounds; Piperazines
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 23 May 1995 Discontinued-Clinical for Anxiety disorders in Canada (PO)
- 23 May 1995 Discontinued-Clinical for Anxiety disorders in Japan (PO)
- 23 May 1995 Discontinued-Clinical for Anxiety disorders in USA (PO)